ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 667875 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 667875; 2) Community: the network communities that were significantly associated with the response to NSC 667875; 3) Molecule: the relationships between components within communities and NSC 667875; 4) MDR: the compounds that were significantly associated with the NSC 667875.

NSC Compound Enrichment Correlation
NSC 682689 2,4,16-Tribromoestra-1,3,5(10)-trien-3-ol-17-one 0.00896740831404549 0.13698926
NSC 689865 Null 0.00896740831404549 0.14943586
NSC 690035 Null 0.00896740831404549 0.31246753
NSC 700125 Null 0.00896740831404549 0.19726933
NSC 710587 Null 0.00896740831404549 0.41820601
NSC 727049 11-(6'-Aminohexylidene]-5,6-dihydro-5-keto-2,3-dimethoxy-6-m ethyl-8,9-methylenedioxy-11H-indeno[1,2-c]isoquinoline 0.00896740831404549 0.29278271
NSC 732841 1-[4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihydro-1H-3-pyrrolyla mino)phenylcarboxamido]-3-trifluoromethylbenzene 0.00896740831404549 0.18141135
NSC 746087 1-(7-Fluoro-3-methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone 0.00896740831404549 0.23343881
NSC 758662 Lovastatin [USAN] 0.00896740831404549 -0.074393337
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.00896740831404568 0.26243883
Total:72  Current:15    [First] [Prev] [Next] [Last]